Wilson Sonsini Goodrich & Rosati advised Replace Therapeutics on the transaction. Tome Biosciences, Inc., a programmable genomic integration (PGI) company, announced that it has acquired Replace...
Wilson Sonsini Goodrich & Rosati advised Replace Therapeutics on the transaction. Tome Biosciences, Inc., a programmable genomic integration (PGI) company, announced that it has acquired Replace...